NS

Neil Spector

DU Duke University: 6 patents #202 of 2,315Top 9%
IM Immunolight: 5 patents #28 of 43Top 70%
GL Glaxosmithkline: 3 patents #112 of 646Top 20%
SL Smithkline Beecham (Cork) Limited: 1 patents #10 of 32Top 35%
📍 Durham, NC: #477 of 4,103 inventorsTop 15%
🗺 North Carolina: #4,713 of 45,564 inventorsTop 15%
Overall (All Time): #443,151 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
11992697 X-ray psoralen activated cancer therapy (X-PACT) Mark F. Oldham, Zakaryae Fathi, Wayne F. Beyer, Jr., Frederic A. Bourke, Jr., Harold Walder +7 more 2024-05-28
11305131 X-ray psoralen activated cancer therapy (X-PACT) Mark F. Oldham, Zakaryae Fathi, Wayne F. Beyer, Jr., Frederic A. Bourke, Jr., Harold Walder +7 more 2022-04-19
11207409 X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments Frederic A. Bourke, Jr., Mark W. Dewhirst, Paul Yoon, Justus Adamson, David Alcorta +7 more 2021-12-28
10441810 X-ray psoralen activated cancer therapy (X-PACT) Mark F. Oldham, Zakaryae Fathi, Wayne F. Beyer, Jr., Harold Walder, Frederic A. Bourke, Jr. +7 more 2019-10-15
9937178 Methods of identifying and using MDM2 inhibitors Sally Kornbluth, Manabu Kurokawa, Mark W. Dewhirst 2018-04-10
9439897 Use of psoralen derivatives and combination therapy for treatment of cell proliferation disorders Wenle Xia, David Gooden, Erik Soderblom, Eric J. Toone, Wayne F. Beyer, Jr. +1 more 2016-09-13
8444988 Cancer treatment method Karen Elizabeth Lackey, Robert J. Mullin, Edgar Raymond Wood, III, Wenle Xia 2013-05-21
7829297 Treatment of cancers expressing p95 ErbB2 Wenle Xia 2010-11-09
7794960 Predictive biomarkers in cancer therapy Albert Man 2010-09-14
7141576 Cancer treatment method Karen Elizabeth Lackey, Edgar Raymond Wood, III., Wenle Xia 2006-11-28
6277844 Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis Sydney Spector 2001-08-21